Induced pluripotency enables differentiation of human nullipotent embryonal carcinoma cells N2102Ep

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2611-2619

  Sutiwisesak, Rujapope ^a,b   Kitiyanant, Narisorn ^a   Kotchabhakdi, Naiphinich ^a   Felsenfeld, Gary ^b   Andrews, Peter W ^c   Wongtrakoongate, Patompon ^b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Embryonal carcinoma cell; Induced pluripotency; Nullipotency

Indexed keywords

A2B5 PROTEIN; B159 PROTEIN; CELL SURFACE MARKER; DOXYCYCLINE; HOX PROTEIN; HOXB9 PROTEIN; KRUPPEL LIKE FACTOR 4; MICROTUBULE ASSOCIATED PROTEIN 2; MYC PROTEIN; NESTIN; NEUROGENIC DIFFERENTIATION FACTOR; NEURON SPECIFIC NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN S100B; PUROMYCIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; SMALL INTERFERING RNA; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX2; TUJ1 PROTEIN; UNCLASSIFIED DRUG; VIN2PB22 PROTEIN; VINIS56 PROTEIN;

ARTICLE; CELL DEATH; CELL LINEAGE; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYONAL CARCINOMA CELL LINE; EPIGENETICS; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYBRIDOMA CELL LINE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; N2102EP CELL LINE; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROECTODERM; NTERA2 CELL LINE; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84905660113     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.07.013     Document Type: Article

References (46)

1. Rajpert-de Meyts E., Hoei-Hansen C.E. From gonocytes to testicular cancer: the role of impaired gonadal development. Ann. N. Y. Acad. Sci. 2007, 1120:168-180.
2. Oosterhuis J.W., Looijenga L.H. Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer 2005, 5:210-222.
3. Andrews P.W., Matin M.M., Bahrami A.R., Damjanov I., Gokhale P., Draper J.S. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem. Soc. Trans. 2005, 33:1526-1530.
4. Zetter B.R., Martin G.R. Expression of a high molecular weight cell surface glycoprotein (LETS protein) by preimplantation mouse embryos and teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:2324-2328.
5. Andrews P.W., Goodfellow P.N. Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells. Somat. Cell Genet. 1980, 6:271-284.
6. Rosenstraus M.J., Balint R.F., Levine A.J. Pluripotency of somatic cell hybrids between nullipotent and pluripotent embryonal carcinoma cells. Somat. Cell Genet. 1980, 6:555-565.
7. Atsumi T., Shirayoshi Y., Takeichi M., Okada T.S. Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells. Differentiation 1982, 23:83-86.
8. Rousset J.P., Bucchini D., Jami J. Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice. Dev. Biol. 1983, 96:331-336.
9. Andrews P.W., Damjanov I., Simon D., Banting G.S., Carlin C., Dracopoli N.C., Fogh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab. Investig. 1984, 50:147-162.
10. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 1984, 103:285-293.
11. Pera M.F., Blasco Lafita M.J., Mills J. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. Int. J. Cancer 1987, 40:334-343.
12. Damjanov I., Horvat B., Gibas Z. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab. Investig. 1993, 68:220-232.
13. Matthaei K.I., Andrews P.W., Bronson D.L. Retinoic acid fails to induce differentiation in human teratocarcinoma cell lines that express high levels of a cellular receptor protein. Exp. Cell Res. 1983, 143:471-474.
14. Duran C., Talley P.J., Walsh J., Pigott C., Morton I.E., Andrews P.W. Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: partial retention of a pluripotent phenotype. Int. J. Cancer 2001, 93:324-332.
15. Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., Meisner L., Zwaka T.P., Thomson J.A., Andrews P.W. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 2004, 22:53-54.
16. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Heath P.R., Holden H., Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 2007, 25:207-215.
17. Amps K., Andrews P.W., Anyfantis G., Armstrong L., Avery S., Baharvand H., Baker J., Baker D., Munoz M.B., Beil S., Benvenisty N., Ben-Yosef D., Biancotti J.C., Bosman A., Brena R.M., Brison D., Caisander G., Camarasa M.V., Chen J., Chiao E., Choi Y.M., Choo A.B., Collins D., Colman A., Crook J.M., Daley G.Q., Dalton A., De Sousa P.A., Denning C., Downie J., Dvorak P., Montgomery K.D., Feki A., Ford A., Fox V., Fraga A.M., Frumkin T., Ge L., Gokhale P.J., Golan-Lev T., Gourabi H., Gropp M., Lu G., Hampl A., Harron K., Healy L., Herath W., Holm F., Hovatta O., Hyllner J., Inamdar M.S., Irwanto A.K., Ishii T., Jaconi M., Jin Y., Kimber S., Kiselev S., Knowles B.B., Kopper O., Kukharenko V., Kuliev A., Lagarkova M.A., Laird P.W., Lako M., Laslett A.L., Lavon N., Lee D.R., Lee J.E., Li C., Lim L.S., Ludwig T.E., Ma Y., Maltby E., Mateizel I., Mayshar Y., Mileikovsky M., Minger S.L., Miyazaki T., Moon S.Y., Moore H., Mummery C., Nagy A., Nakatsuji N., Narwani K., Oh S.K., Oh S.K., Olson C., Otonkoski T., Pan F., Park I.H., Pells S., Pera M.F., Pereira L.V., Qi O., Raj G.S., Reubinoff B., Robins A., Robson P., Rossant J., Salekdeh G.H., Schulz T.C., Sermon K., Sheik Mohamed J., Shen H., Sherrer E., Sidhu K., Sivarajah S., Skottman H., Spits C., Stacey G.N., Strehl R., Strelchenko N., Suemori H., Sun B., Suuronen R., Takahashi K., Tuuri T., Venu P., Verlinsky Y., Ward-van Oostwaard D., Weisenberger D.J., Wu Y., Yamanaka S., Young L., Zhou Q. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 2011, 29:1132-1144.
18. Mavilio F., Simeone A., Boncinelli E., Andrews P.W. Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid. Differentiation 1988, 37:73-79.
19. Zhang X., Huang C.T., Chen J., Pankratz M.T., Xi J., Li J., Yang Y., Lavaute T.M., Li X.J., Ayala M., Bondarenko G.I., Du Z.W., Jin Y., Golos T.G., Zhang S.C. Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell 2010, 7:90-100.
20. Blelloch R.H., Hochedlinger K., Yamada Y., Brennan C., Kim M., Mintz B., Chin L., Jaenisch R. Nuclear cloning of embryonal carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:13985-13990.
21. Draper J.S., Pigott C., Thomson J.A., Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 2002, 200:249-258.
22. Josephson R., Ording C.J., Liu Y., Shin S., Lakshmipathy U., Toumadje A., Love B., Chesnut J.D., Andrews P.W., Rao M.S., Auerbach J.M. Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Stem Cells 2007, 25:437-446.
23. Sperger J.M., Chen X., Draper J.S., Antosiewicz J.E., Chon C.H., Jones S.B., Brooks J.D., Andrews P.W., Brown P.O., Thomson J.A. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13350-13355.
24. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
25. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
26. Andrews P.W., Goodfellow P.N., Shevinsky L.H., Bronson D.L., Knowles B.B. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int. J. Cancer 1982, 29:523-531.
27. Zafarana G., Avery S.R., Avery K., Moore H.D., Andrews P.W. Specific knockdown of OCT4 in human embryonic stem cells by inducible short hairpin RNA interference. Stem Cells 2009, 27:776-782.
28. Wongtrakoongate P., Li J., Andrews P.W. DNMT3B inhibits the re-expression of genes associated with induced pluripotency. Exp. Cell Res. 2014, 321:231-239.
29. Matin M.M., Walsh J.R., Gokhale P.J., Draper J.S., Bahrami A.R., Morton I., Moore H.D., Andrews P.W. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 2004, 22:659-668.
30. Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W., Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., Blum B., Brooking J., Chen K.G., Choo A.B., Churchill G.A., Corbel M., Damjanov I., Draper J.S., Dvorak P., Emanuelsson K., Fleck R.A., Ford A., Gertow K., Gertsenstein M., Gokhale P.J., Hamilton R.S., Hampl A., Healy L.E., Hovatta O., Hyllner J., Imreh M.P., Itskovitz-Eldor J., Jackson J., Johnson J.L., Jones M., Kee K., King B.L., Knowles B.B., Lako M., Lebrin F., Mallon B.S., Manning D., Mayshar Y., McKay R.D., Michalska A.E., Mikkola M., Mileikovsky M., Minger S.L., Moore H.D., Mummery C.L., Nagy A., Nakatsuji N., O'Brien C.M., Oh S.K., Olsson C., Otonkoski T., Park K.Y., Passier R., Patel H., Patel M., Pedersen R., Pera M.F., Piekarczyk M.S., Pera R.A., Reubinoff B.E., Robins A.J., Rossant J., Rugg-Gunn P., Schulz T.C., Semb H., Sherrer E.S., Siemen H., Stacey G.N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T., Tuuri T., van den Brink S., Vintersten K., Vuoristo S., Ward D., Weaver T.A., Young L.A., Zhang W. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 2007, 25:803-816.
31. Moasser M.M., DeBlasio A., Dmitrovsky E. Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas. Oncogene 1994, 9:833-840.
32. Moasser M.M., Khoo K.S., Maerz W.J., Zelenetz A., Dmitrovsky E. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells. Differentiation 1996, 60:251-257.
33. Moasser M.M., Reuter V.E., Dmitrovsky E. Overexpression of the retinoic acid receptor gamma directly induces terminal differentiation of human embryonal carcinoma cells. Oncogene 1995, 10:1537-1543.
34. Marchetto M.C., Yeo G.W., Kainohana O., Marsala M., Gage F.H., Muotri A.R. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009, 4:e7076.
35. Ghosh Z., Wilson K.D., Wu Y., Hu S., Quertermous T., Wu J.C. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 2010, 5:e8975.
36. Polo J.M., Liu S., Figueroa M.E., Kulalert W., Eminli S., Tan K.Y., Apostolou E., Stadtfeld M., Li Y., Shioda T., Natesan S., Wagers A.J., Melnick A., Evans T., Hochedlinger K. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 2010, 28:848-855.
37. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., Kim J., Aryee M.J., Ji H., Ehrlich L.I., Yabuuchi A., Takeuchi A., Cunniff K.C., Hongguang H., McKinney-Freeman S., Naveiras O., Yoon T.J., Irizarry R.A., Jung N., Seita J., Hanna J., Murakami P., Jaenisch R., Weissleder R., Orkin S.H., Weissman I.L., Feinberg A.P., Daley G.Q. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
38. Wongtrakoongate P., Jones M., Gokhale P.J., Andrews P.W. STELLA facilitates differentiation of germ cell and endodermal lineages of human embryonic stem cells. PLoS One 2013, 8:e56893.
39. Dai B., Rasmussen T.P. Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. Stem Cells 2007, 25:2567-2574.
40. Jin B., Ernst J., Tiedemann R.L., Xu H., Sureshchandra S., Kellis M., Dalton S., Liu C., Choi J.H., Robertson K.D. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell rep. 2012, 2:1411-1424.
41. Nettersheim D., Heukamp L.C., Fronhoffs F., Grewe M.J., Haas N., Waha A., Honecker F., Waha A., Kristiansen G., Schorle H. Analysis of TET expression/activity and 5mC oxidation during normal and malignant germ cell development. PLoS One 2013, 8:e82881.
42. Kristensen D.G., Nielsen J.E., Jorgensen A., Skakkebaek N.E., Rajpert-De Meyts E., Almstrup K. Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis. Br. J. Cancer 2014, 110:668-678.
43. Kristensen D.G., Skakkebaek N.E., Rajpert-De Meyts E., Almstrup K. Epigenetic features of testicular germ cell tumours in relation to epigenetic characteristics of foetal germ cells. Int. J. Dev. Biol. 2013, 57:309-317.
44. Van Der Zwan Y.G., Stoop H., Rossello F., White S.J., Looijenga L.H. Role of epigenetics in the etiology of germ cell cancer. Int. J. Dev. Biol. 2013, 57:299-308.
45. Kim K.P., Thurston A., Mummery C., Ward-van Oostwaard D., Priddle H., Allegrucci C., Denning C., Young L. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res. 2007, 17:1731-1742.
46. Bibikova M., Chudin E., Wu B., Zhou L., Garcia E.W., Liu Y., Shin S., Plaia T.W., Auerbach J.M., Arking D.E., Gonzalez R., Crook J., Davidson B., Schulz T.C., Robins A., Khanna A., Sartipy P., Hyllner J., Vanguri P., Savant-Bhonsale S., Smith A.K., Chakravarti A., Maitra A., Rao M., Barker D.L., Loring J.F., Fan J.B. Human embryonic stem cells have a unique epigenetic signature. Genome Res. 2006, 16:1075-1083.